By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – TriLink BioTechnologies and Lucigen today announced a deal for the use of TriLink's CleanAmp dNTPs in Lucigen's Taq98 Hot Start 2X MasterMix.

In a statement, the companies said that a Hot Start reaction can be achieved by replacing the standard dNTPs in a PCR assay with CleanAmp dNTP, resulting in a cost-effective method to "vastly reduce mis-priming."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.